Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep982 | Pituitary - Clinical | ECE2017

The triglyceride (TG)/HDL Cholesterol (TG/HDL-C) ratio as marker of adipose tissue dysfunction at patients with acromegaly

Khyzhnyak Oksana , Mykytyk Miroslava , Karachentsev Iurii

Background and aims: The ratio of TG/ HDL-C can identify cardiometabolic risk and cardiovascular disease. The visceral adiposity index (VAI) is a sex-specific index, in which measurements of body mass index and waist circumference are combined with TG and HDL-C concentrations. T? study association between VAI and TG/HDL-C and the value of TG/HDL-C ratio as a marker of disfunction of visceral adiposity tissue at patients with acromegaly.Subjects and metho...

ea0099ep104 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Quality of life of patients with diabetes type 1 and type 2 in the conditions of military conflict

Khyzhnyak Oksana , Mykytyk Miroslava , Karachentsev Urii

The military conflict in Ukraine triggered the internal migration of millions of Ukrainians. Internally displaced persons (IDPs) and residents of territorial communities (RTCs) located in zones of war with Diabetes mellitus (DM) are at high risk of developing post-traumatic stress disorder (PTSD), anxiety and depression.The aim of the study was to assess the health-related quality of life (HRQoL) of patients with DM type 1 (DM T1) and type 2 (DM T2) in the con...

ea0049ep983 | Pituitary - Clinical | ECE2017

Anti-proliferative effects of high doses cabergoline in patients with prolactinoma

Khyzhnyak Oksana , Gogitidze Teona , Mykytyk Miroslava , Karachentsev Iurii , Barabash Nadiya , Manskaya Katerina

The aim of the study: To investigate the anti-proliferative effect of cabergoline (CAB) which was used in different regimes of suppressive therapy during 12 months in patients with prolactinoma (PROL).Subjects and methods: It was examined and underwent a 12 month course of treatment by selective dopamine agonist CAB 61 patients with PROL: microadenoma 42, macro&giant PROL - 19. (52 women/9 men) aged 16–66 years. The total duration of the disease...